Canada markets open in 2 hours 43 minutes

Canntab Therapeutics Limited (TBF1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.6050-0.0100 (-1.63%)
As of 8:00AM CET. Market open.

Canntab Therapeutics Limited

223 Riviera Drive
Markham, ON L3R 5J6
Canada
289 301 3812
http://canntab.ca

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Jeffrey Ward RenwickCo-Founder, Pres, Head of Production & ChairmanN/AN/A1971
Mr. Richard C. GoldsteinCo-Founder, CFO & DirectorN/AN/A1962
Mr. Barry M. PolisukSec. & Independent DirectorN/AN/A1960
Mr. Lawrence LatowskyChief Exec. OfficerN/AN/A1960
Mr. Joshi LaxminarayanChief Scientific OfficerN/AN/AN/A
Mr. Eric MalinskiDirector of MarketingN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Canntab Therapeutics Limited, a biopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids, tetrahydrocannabinol, and terpenes in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.

Corporate Governance

Canntab Therapeutics Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.